IGHA1 and inflammatory bowel disease: De‐sialylation of IgA1 in IBD may thus affect the recognition of commensals themselves and is consistent with enrichment of beneficial Faecalibactierum in the IgA1+ fraction of our CD patients' microbiota (Fig. 4G).